| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88975405 | FILING DATE | 06/25/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | VO, JULIE |
L.O. ASSIGNED | N50-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 12/07/2019 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 12/06/2019 | ||
| LITERAL MARK ELEMENT | R X + | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | R X + |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Astellas Pharma Inc. |
| ADDRESS | 5-1, Nihonbashi-Honcho 2-chome Chuo-ku, Tokyo, |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Japan |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Medical apparatus for detecting and treating for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and diagnostic imaging |
| INTERNATIONAL CLASS | 041 |
| DESCRIPTION TEXT | Instruction in the field of dosage management; entertainment services, namely, providing online computer games; providing therapeutic exercise instruction; sports club services, namely, physical fitness instruction |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Medical service, medical diagnostic testing services, surgery support services related to medical care for type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 041 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | Color is not claimed as a feature of the mark. |
| DISCLAIMER W/PREDETER TXT | "RX" |
| DESCRIPTION OF MARK | The mark consists of the letters "R" and "X" and a plus sign. |
| PSEUDO MARK | R X PLUS |
| CHILD OF | 88013089 |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/06/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 023 |
| 11/06/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 022 |
| 11/06/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 021 |
| 11/06/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 020 |
| 11/06/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 019 |
| 06/17/2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 018 |
| 06/17/2019 | GNFR | O | FINAL REFUSAL E-MAILED | 017 |
| 06/17/2019 | CNFR | R | FINAL REFUSAL WRITTEN | 016 |
| 06/13/2019 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 015 |
| 06/12/2019 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | 014 |
| 04/22/2019 | DRRR | I | DIVISIONAL REQUEST RECEIVED | 013 |
| 06/12/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 012 |
| 04/22/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 011 |
| 04/22/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 010 |
| 04/22/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 009 |
| 04/22/2019 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | 008 |
| 10/23/2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 007 |
| 10/23/2018 | GNRT | F | NON-FINAL ACTION E-MAILED | 006 |
| 10/23/2018 | CNRT | R | NON-FINAL ACTION WRITTEN | 005 |
| 10/02/2018 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 06/30/2018 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 06/29/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 06/28/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Kathleen Gallagher-Duff |
| CORRESPONDENCE ADDRESS | KATHLEEN GALLAGHER-DUFF COVINGTON & BURLING LLP ONE CITYCENTER, 850 TENTH STREET NW WASHINGTON, DC 20001 |
| DOMESTIC REPRESENTATIVE | NONE |